Cargando…
A perfused human blood–brain barrier on-a-chip for high-throughput assessment of barrier function and antibody transport
BACKGROUND: Receptor-mediated transcytosis is one of the major routes for drug delivery of large molecules into the brain. The aim of this study was to develop a novel model of the human blood–brain barrier (BBB) in a high-throughput microfluidic device. This model can be used to assess passage of l...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6117964/ https://www.ncbi.nlm.nih.gov/pubmed/30165870 http://dx.doi.org/10.1186/s12987-018-0108-3 |
_version_ | 1783351848953970688 |
---|---|
author | Wevers, Nienke R. Kasi, Dhanesh G. Gray, Taylor Wilschut, Karlijn J. Smith, Benjamin van Vught, Remko Shimizu, Fumitaka Sano, Yasuteru Kanda, Takashi Marsh, Graham Trietsch, Sebastiaan J. Vulto, Paul Lanz, Henriëtte L. Obermeier, Birgit |
author_facet | Wevers, Nienke R. Kasi, Dhanesh G. Gray, Taylor Wilschut, Karlijn J. Smith, Benjamin van Vught, Remko Shimizu, Fumitaka Sano, Yasuteru Kanda, Takashi Marsh, Graham Trietsch, Sebastiaan J. Vulto, Paul Lanz, Henriëtte L. Obermeier, Birgit |
author_sort | Wevers, Nienke R. |
collection | PubMed |
description | BACKGROUND: Receptor-mediated transcytosis is one of the major routes for drug delivery of large molecules into the brain. The aim of this study was to develop a novel model of the human blood–brain barrier (BBB) in a high-throughput microfluidic device. This model can be used to assess passage of large biopharmaceuticals, such as therapeutic antibodies, across the BBB. METHODS: The model comprises human cell lines of brain endothelial cells, astrocytes, and pericytes in a two-lane or three-lane microfluidic platform that harbors 96 or 40 chips, respectively, in a 384-well plate format. In each chip, a perfused vessel of brain endothelial cells was grown against an extracellular matrix gel, which was patterned by means of surface tension techniques. Astrocytes and pericytes were added on the other side of the gel to complete the BBB on-a-chip model. Barrier function of the model was studied using fluorescent barrier integrity assays. To test antibody transcytosis, the lumen of the model’s endothelial vessel was perfused with an anti-transferrin receptor antibody or with a control antibody. The levels of antibody that penetrated to the basal compartment were quantified using a mesoscale discovery assay. RESULTS: The perfused BBB on-a-chip model shows presence of adherens and tight junctions and severely limits the passage of a 20 kDa FITC-dextran dye. Penetration of the antibody targeting the human transferrin receptor (MEM-189) was markedly higher than penetration of the control antibody (apparent permeability of 2.9 × 10(−5) versus 1.6 × 10(−5) cm/min, respectively). CONCLUSIONS: We demonstrate successful integration of a human BBB microfluidic model in a high-throughput plate-based format that can be used for drug screening purposes. This in vitro model shows sufficient barrier function to study the passage of large molecules and is sensitive to differences in antibody penetration, which could support discovery and engineering of BBB-shuttle technologies. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12987-018-0108-3) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-6117964 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-61179642018-09-05 A perfused human blood–brain barrier on-a-chip for high-throughput assessment of barrier function and antibody transport Wevers, Nienke R. Kasi, Dhanesh G. Gray, Taylor Wilschut, Karlijn J. Smith, Benjamin van Vught, Remko Shimizu, Fumitaka Sano, Yasuteru Kanda, Takashi Marsh, Graham Trietsch, Sebastiaan J. Vulto, Paul Lanz, Henriëtte L. Obermeier, Birgit Fluids Barriers CNS Research BACKGROUND: Receptor-mediated transcytosis is one of the major routes for drug delivery of large molecules into the brain. The aim of this study was to develop a novel model of the human blood–brain barrier (BBB) in a high-throughput microfluidic device. This model can be used to assess passage of large biopharmaceuticals, such as therapeutic antibodies, across the BBB. METHODS: The model comprises human cell lines of brain endothelial cells, astrocytes, and pericytes in a two-lane or three-lane microfluidic platform that harbors 96 or 40 chips, respectively, in a 384-well plate format. In each chip, a perfused vessel of brain endothelial cells was grown against an extracellular matrix gel, which was patterned by means of surface tension techniques. Astrocytes and pericytes were added on the other side of the gel to complete the BBB on-a-chip model. Barrier function of the model was studied using fluorescent barrier integrity assays. To test antibody transcytosis, the lumen of the model’s endothelial vessel was perfused with an anti-transferrin receptor antibody or with a control antibody. The levels of antibody that penetrated to the basal compartment were quantified using a mesoscale discovery assay. RESULTS: The perfused BBB on-a-chip model shows presence of adherens and tight junctions and severely limits the passage of a 20 kDa FITC-dextran dye. Penetration of the antibody targeting the human transferrin receptor (MEM-189) was markedly higher than penetration of the control antibody (apparent permeability of 2.9 × 10(−5) versus 1.6 × 10(−5) cm/min, respectively). CONCLUSIONS: We demonstrate successful integration of a human BBB microfluidic model in a high-throughput plate-based format that can be used for drug screening purposes. This in vitro model shows sufficient barrier function to study the passage of large molecules and is sensitive to differences in antibody penetration, which could support discovery and engineering of BBB-shuttle technologies. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12987-018-0108-3) contains supplementary material, which is available to authorized users. BioMed Central 2018-08-31 /pmc/articles/PMC6117964/ /pubmed/30165870 http://dx.doi.org/10.1186/s12987-018-0108-3 Text en © The Author(s) 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Wevers, Nienke R. Kasi, Dhanesh G. Gray, Taylor Wilschut, Karlijn J. Smith, Benjamin van Vught, Remko Shimizu, Fumitaka Sano, Yasuteru Kanda, Takashi Marsh, Graham Trietsch, Sebastiaan J. Vulto, Paul Lanz, Henriëtte L. Obermeier, Birgit A perfused human blood–brain barrier on-a-chip for high-throughput assessment of barrier function and antibody transport |
title | A perfused human blood–brain barrier on-a-chip for high-throughput assessment of barrier function and antibody transport |
title_full | A perfused human blood–brain barrier on-a-chip for high-throughput assessment of barrier function and antibody transport |
title_fullStr | A perfused human blood–brain barrier on-a-chip for high-throughput assessment of barrier function and antibody transport |
title_full_unstemmed | A perfused human blood–brain barrier on-a-chip for high-throughput assessment of barrier function and antibody transport |
title_short | A perfused human blood–brain barrier on-a-chip for high-throughput assessment of barrier function and antibody transport |
title_sort | perfused human blood–brain barrier on-a-chip for high-throughput assessment of barrier function and antibody transport |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6117964/ https://www.ncbi.nlm.nih.gov/pubmed/30165870 http://dx.doi.org/10.1186/s12987-018-0108-3 |
work_keys_str_mv | AT weversnienker aperfusedhumanbloodbrainbarrieronachipforhighthroughputassessmentofbarrierfunctionandantibodytransport AT kasidhaneshg aperfusedhumanbloodbrainbarrieronachipforhighthroughputassessmentofbarrierfunctionandantibodytransport AT graytaylor aperfusedhumanbloodbrainbarrieronachipforhighthroughputassessmentofbarrierfunctionandantibodytransport AT wilschutkarlijnj aperfusedhumanbloodbrainbarrieronachipforhighthroughputassessmentofbarrierfunctionandantibodytransport AT smithbenjamin aperfusedhumanbloodbrainbarrieronachipforhighthroughputassessmentofbarrierfunctionandantibodytransport AT vanvughtremko aperfusedhumanbloodbrainbarrieronachipforhighthroughputassessmentofbarrierfunctionandantibodytransport AT shimizufumitaka aperfusedhumanbloodbrainbarrieronachipforhighthroughputassessmentofbarrierfunctionandantibodytransport AT sanoyasuteru aperfusedhumanbloodbrainbarrieronachipforhighthroughputassessmentofbarrierfunctionandantibodytransport AT kandatakashi aperfusedhumanbloodbrainbarrieronachipforhighthroughputassessmentofbarrierfunctionandantibodytransport AT marshgraham aperfusedhumanbloodbrainbarrieronachipforhighthroughputassessmentofbarrierfunctionandantibodytransport AT trietschsebastiaanj aperfusedhumanbloodbrainbarrieronachipforhighthroughputassessmentofbarrierfunctionandantibodytransport AT vultopaul aperfusedhumanbloodbrainbarrieronachipforhighthroughputassessmentofbarrierfunctionandantibodytransport AT lanzhenriettel aperfusedhumanbloodbrainbarrieronachipforhighthroughputassessmentofbarrierfunctionandantibodytransport AT obermeierbirgit aperfusedhumanbloodbrainbarrieronachipforhighthroughputassessmentofbarrierfunctionandantibodytransport AT weversnienker perfusedhumanbloodbrainbarrieronachipforhighthroughputassessmentofbarrierfunctionandantibodytransport AT kasidhaneshg perfusedhumanbloodbrainbarrieronachipforhighthroughputassessmentofbarrierfunctionandantibodytransport AT graytaylor perfusedhumanbloodbrainbarrieronachipforhighthroughputassessmentofbarrierfunctionandantibodytransport AT wilschutkarlijnj perfusedhumanbloodbrainbarrieronachipforhighthroughputassessmentofbarrierfunctionandantibodytransport AT smithbenjamin perfusedhumanbloodbrainbarrieronachipforhighthroughputassessmentofbarrierfunctionandantibodytransport AT vanvughtremko perfusedhumanbloodbrainbarrieronachipforhighthroughputassessmentofbarrierfunctionandantibodytransport AT shimizufumitaka perfusedhumanbloodbrainbarrieronachipforhighthroughputassessmentofbarrierfunctionandantibodytransport AT sanoyasuteru perfusedhumanbloodbrainbarrieronachipforhighthroughputassessmentofbarrierfunctionandantibodytransport AT kandatakashi perfusedhumanbloodbrainbarrieronachipforhighthroughputassessmentofbarrierfunctionandantibodytransport AT marshgraham perfusedhumanbloodbrainbarrieronachipforhighthroughputassessmentofbarrierfunctionandantibodytransport AT trietschsebastiaanj perfusedhumanbloodbrainbarrieronachipforhighthroughputassessmentofbarrierfunctionandantibodytransport AT vultopaul perfusedhumanbloodbrainbarrieronachipforhighthroughputassessmentofbarrierfunctionandantibodytransport AT lanzhenriettel perfusedhumanbloodbrainbarrieronachipforhighthroughputassessmentofbarrierfunctionandantibodytransport AT obermeierbirgit perfusedhumanbloodbrainbarrieronachipforhighthroughputassessmentofbarrierfunctionandantibodytransport |